BridgeBio Pharma BBIO
$76.03 −$2.15 (-2.75%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $76.03 0.00%
Open$77.85
Prev close$78.18
Day range$75.46 – $78.24
Volume1.48M
Market cap$14.81B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts16
Average target$110.00+44.7% vs. price
- Buy 94%
- Hold 6%
Low $91.00Now $76.03Avg $110.00High $156.00
Recent rating changes
The last 20 actions on file set price targets from $87.00 to $156.00, averaging $104.58.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 20 Nov 2026 | Piper Sandler | BUY | $120.00 |
| 13 Nov 2026 | Morgan Stanley | BUY | $91.00 |
| 2 Nov 2026 | CCORF | BUY | $108.00 |
| 2 Nov 2026 | Barclays | BUY | $156.00 |
| 30 Oct 2026 | Wells Fargo | BUY | $102.00 |
| 30 Oct 2026 | UBS | BUY | $92.00 |
| 30 Oct 2026 | Piper Sandler | BUY | $120.00 |
| 30 Oct 2026 | BofA Securities | BUY | – |
| 30 Oct 2026 | Morgan Stanley | BUY | $88.00 |
| 30 Oct 2026 | Evercore | BUY | $130.00 |
| 30 Oct 2026 | Citi | HOLD | $91.00 |
| 30 Oct 2026 | RBC Capital | BUY | $100.00 |
| 29 Oct 2026 | TD Cowen | BUY | $100.00 |
| 29 Oct 2026 | Cantor Fitzgerald | BUY | $110.00 |
| 29 Oct 2026 | Wells Fargo | BUY | $102.00 |
| 25 Oct 2026 | Cantor Fitzgerald | BUY | $110.00 |
| 22 Oct 2026 | Morgan Stanley | BUY | $87.00 |
| 21 Oct 2026 | Morgan Stanley | BUY | $87.00 |
| 20 Oct 2026 | Citi | HOLD | $91.00 |
| 19 Oct 2026 | BofA Securities | BUY | $102.00 |
No comments yet — be the first to weigh in on BBIO.
Sign in to join the discussion.